Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Stability of Zika Virus Antibodies in Specimens from a Retrospective Serological Study.
Journal: The American journal of tropical medicine and hygiene
Published: July 27, 2021
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand.
Journal: Human immunology
Published: March 01, 2021
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial.
Journal: Human vaccines & immunotherapeutics
Published: February 24, 2021
Spatiotemporal Heterogeneity of Zika Virus Transmission in Indonesia: Serosurveillance Data from a Pediatric Population.
Journal: The American journal of tropical medicine and hygiene
Published: January 05, 2021
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 01, 2020
Corrigendum to: Dengue Endemicity, Force of Infection and Variation in Transmission Intensity From 13 Endemic Countries.
Journal: The Journal of infectious diseases
Published: May 19, 2020
Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.
Journal: Vaccine
Published: April 27, 2020
Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus.
Journal: Vaccine
Published: December 11, 2019
Dengue Endemicity, Force of Infection, and Variation in Transmission Intensity in 13 Endemic Countries.
Journal: The Journal of infectious diseases
Published: November 19, 2019
Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series.
Journal: Human vaccines & immunotherapeutics
Published: August 30, 2019
Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response.
Journal: The American journal of tropical medicine and hygiene
Published: May 23, 2019
Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials.
Journal: Human vaccines & immunotherapeutics
Published: February 07, 2019
Last Updated: 09/26/2026